Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma

Table 3

Subgroup log-rank analysis of miR-17 expression and prognosis in patients with different pathological grades.

WHO grade	miR-17 expression status	5-year overall survival (%)	𝑃
I~II	High	60.0	0.1
	Low	80.0
III~IV	High	18.2	<0.001
	Low	52.2